Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia

Bone Marrow Transplantation volume 39, pages 631–635 (2007)Cite this article

Abstract

Antifungal therapy may be unable to eradicate invasive mycosis in leukemia patients. The presence of persisting pulmonary nodules owing to mycosis seems to increase the risk of fungal relapse after chemotherapy and transplant procedures. Between 1997 and 2004, 10 acute leukemia patients underwent pulmonary surgery for invasive mycosis. The median time from diagnosis of mycosis to surgery was 135 days (range 21–147). Three patients underwent emergency surgery, owing to hemoptysis. In the other seven patients with nodule/cavitation remaining after antifungal treatment, surgery (three wedge resections, four lobectomies) was scheduled before transplant. Pathologic examination confirmed two aspergillosis and three zygomycosis. The only side effect was pneumothorax in one case. Nine patients were considered cured. Six patients underwent bone marrow transplantation (three allogeneic, three autologous) with antifungal prophylaxis without relapse during the transplant procedure. In selected patients scheduled for bone marrow transplantation, surgical resection of localized pulmonary fungus nodules combined with antifungal prophylaxis seem to be an effective treatment for preventing mycotic relapse.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. McNeil MM, Nash SL, Hajjek RA, Phelam MA, Conn LA, Plikaytis BD et al. Trends in mortality due to invasive mycotic disease in United States, 1980–1997. Clin Infect Dis 2001; 33: 641–647.

    Article  CAS  Google Scholar 

  2. Lin SJ, Schranz J, Teutsch SM . Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358–366.

    Article  CAS  Google Scholar 

  3. Marr K, Lavardiere M, Gugel A, Leinsering W . Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762–1769.

    Article  CAS  Google Scholar 

  4. Jantunen E, Ruutu P, Piilonen A, Volin L, Parkkali T, Ruutu T . Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Trasplant 2000; 26: 759–762.

    Article  CAS  Google Scholar 

  5. Sipsas NK, Kontoyiannis DP . Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies. Clin Infect Dis 2006; 42: 1584–1591.

    Article  Google Scholar 

  6. Kibbler CC, Milkins SR, Bahamra A, Spiteri MA, Noone P, Prentice HG . Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients. Thorax 1988; 43: 108–112.

    Article  CAS  Google Scholar 

  7. Pagano L, Ricci P, Nosari A, Tonso A, Buelli M, Montillo M et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukemia in hematological complete remission. A retrospective study and review of literature. Br J Haematol 1995; 89: 500–505.

    Article  CAS  Google Scholar 

  8. Meyers JD . Fungal infections in bone marrow transplant patients. Semin Oncol 1990; 17: 10–13.

    CAS  PubMed  Google Scholar 

  9. Todeschini G, Murari C, Bonesi R, Zizzolo G, Verlato G, Tecchio C et al. Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest 1999; 29: 453–457.

    Article  CAS  Google Scholar 

  10. Avivi I, Oren I, Haddad N, Rowe JM, Dann EJ . Stem cell transplantation post invasive fungal infection is a feasible task. Am J Hematol 2004; 75: 6–11.

    Article  Google Scholar 

  11. Martino R, Subira M, Rovira M, Solano C, Vasquez L, Sanz GF et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 2002; 116: 475–482.

    Article  Google Scholar 

  12. Marr KA, Carter RA, Boeckh M, Martin P, Corey L . Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358–4366.

    Article  CAS  Google Scholar 

  13. Ascioglu S, Rex JH, de Paw B, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.

    Article  CAS  Google Scholar 

  14. Denning DW, Marinus A, Cohen J, Spence D, Herbrecht R, Pagano L et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect 1998; 37: 173–180.

    Article  CAS  Google Scholar 

  15. Pagano L, Caira M, Candoni A, Offidani A, Fianchi L, Martino B et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91: 1068–1075.

    PubMed  Google Scholar 

  16. Pagano L, Girmenia C, Mele L, Ricci P, Tosti ME, Nosari A et al. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. Haematologica 2001; 86: 862–870.

    CAS  PubMed  Google Scholar 

  17. Caillot D, Casasnovas O, Bernard A, Couaillier GF, Durand C, Cuisenier B et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomography scan and surgery. J Clin Oncol 1997; 15: 139–147.

    Article  CAS  Google Scholar 

  18. Hoover M, Morgan ER, Kletzel M . Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia. Med Pediatr Oncol 1997; 28: 268–273.

    Article  CAS  Google Scholar 

  19. Wang JT, Yao M, Tang JL, Chang SC, Hung CC . Prior invasive fungal infection is not a contraindication to subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies. J Clin Oncol 2001; 19: 4000–4001.

    Article  CAS  Google Scholar 

  20. Cordonnier C, Maury S, Pautas C, Bastie JN, Chehata S, Castaigne S et al. Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients. Bone Marrow Transplant 2004; 33: 943–949.

    Article  CAS  Google Scholar 

  21. Hoffer AF, Gow K, Flynn PM, Davidoff A . Accuracy of percutaneous lung biopsy for invasive pulmonary aspergillosis. Pediatr Radiol 2001; 31: 144–152.

    Article  CAS  Google Scholar 

  22. Cordonnier C, Escudier E, Verra F, Brochard L, Bernaudin JF, Fleury-Feith J . Bronchoalveolar lavage during neutropenic episodes: diagnostic yeld and cellular pattern. Eur Respir J 1994; 7: 114–120.

    Article  CAS  Google Scholar 

  23. Nosari A, Anghilieri M, Carrafiello G, Guffanti C, Marbello L, Montillo M et al. Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies. Haematologica 2003; 88: 1405–1409.

    PubMed  Google Scholar 

  24. Gonzales CE, Rinaldi MG, Sugar AM . Zygomycosis. Infect Dis Clin North Am 2002; 16: 895–914.

    Article  Google Scholar 

  25. Brown J . Zygomycosis: an emerging fungal infection. Am J Health Syst Pharm 2005; 62: 2593–2596.

    Article  Google Scholar 

  26. Albeda SM, Talbot GM, Gerson SL, Miller WT, Cassileth PA . Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia. Am Rev Respir Dis 1985; 131: 115–120.

    Google Scholar 

  27. Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Piccardi M et al. Mucormycosis in hematologic patients. Haematologica 2004; 89: 207–214.

    PubMed  Google Scholar 

  28. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case–control observational study of 27 recent cases. J Infect Dis 2005; 15: 1350–1360.

    Article  Google Scholar 

  29. Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E . Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma 2004; 45: 1351–1360.

    Article  CAS  Google Scholar 

  30. Nosari A, Oreste PL, Montillo M, Carrafiello G, Draisci M, Muti G et al. Mucormycosis in haematologic malignancies: an emerging fungal infection. Haematologica 2000; 85: 1068–1071.

    CAS  PubMed  Google Scholar 

  31. Reichemberger F, Habicht J, Kaim A, Delquen P, Bernet F, Schlapfer R et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Crit Care Med 1998; 158: 885–889.

    Article  Google Scholar 

  32. Matt P, Bernet F, Habicht J, Gambizzi F, Gratwolh A, Zerkowsli HR et al. Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia. Chest 2004; 126: 1783–1788.

    Article  Google Scholar 

  33. Yeghen T, Kibbler CC, Prentice HG, Berger LA, Wallesby RK, McWhinney PH et al. Management of invasive pulmonary aspergillosis in hematologic patients: a review of 87 consecutive cases at a single institution. Clin Infect Dis 2000; 31: 859–868.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Niguarda Ca'Granda Hospital, Milan, Italy

    A Nosari, R Cairoli, P Cozzi, L Marbello, P Marenco, G Grillo & E Morra

  2. Thoracic Surgery Unit, Niguarda Ca'Granda Hospital, Milan, Italy

    M Ravini

Authors
  1. A Nosari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Ravini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Cairoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Cozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Marbello
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Marenco
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G Grillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E Morra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Nosari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nosari, A., Ravini, M., Cairoli, R. et al. Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia. Bone Marrow Transplant 39, 631–635 (2007). https://doi.org/10.1038/sj.bmt.1705655

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705655

Keywords

This article is cited by

Search

Advanced search

Quick links